Cargando…

Response: Integrating Buprenorphine Therapy Into Clinical Practice

Detalles Bibliográficos
Autores principales:	Doot, Martin C., Payte, J. Thomas, Van Zee, Arthur
Formato:	Texto
Lenguaje:	English
Publicado:	National Institute on Drug Abuse 2004
Materias:	Special Focus: A New Medication for Opioid Addiction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851025/ https://www.ncbi.nlm.nih.gov/pubmed/18552730

Ejemplares similares

Practical Considerations for the Clinical Use of Buprenorphine
por: Jones, Hendrée E.
Publicado: (2004)

Community Treatment Programs Take Up Buprenorphine
por: Casadonte, Paul P., et al.
Publicado: (2004)

Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine
por: Webster, Lynn, et al.
Publicado: (2016)

Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder
por: Kapuganti, Amber, et al.
Publicado: (2018)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales
por: Marteau, Dave, et al.
Publicado: (2015)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment
por: Kong, Yinfei, et al.
Publicado: (2021)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
por: Piske, Micah, et al.
Publicado: (2020)

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
por: Suarez, Edward, et al.
Publicado: (2023)

Consensus Recommendations on Initiating Prescription Therapies for Opioid‐Induced Constipation
por: Argoff, Charles E., et al.
Publicado: (2015)

A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone
por: Webster, Lynn R., et al.
Publicado: (2016)

Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Darwish, Mona, et al.
Publicado: (2017)

ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes
por: Cepeda, M. Soledad, et al.
Publicado: (2017)

Diversion and Illicit Sale of Extended Release Tapentadol in the United States
por: Dart, Richard C., et al.
Publicado: (2016)

One Month of Oral Morphine Decreases Gray Matter Volume in the Right Amygdala of Individuals with Low Back Pain: Confirmation of Previously Reported Magnetic Resonance Imaging Results
por: Lin, Joanne C., et al.
Publicado: (2016)

Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
por: Harris, Stephen C., et al.
Publicado: (2017)

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users
por: Setnik, Beatrice, et al.
Publicado: (2017)

Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid Users
por: Smith, Michael D., et al.
Publicado: (2017)

Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion
por: Webster, Lynn, et al.
Publicado: (2020)

Implementation and results of a symptom-triggered opioid withdrawal protocol at a Veterans Affairs medical center
por: Koch, Jessa, et al.
Publicado: (2018)

Family-focused practices in addictions: a scoping review protocol
por: Kourgiantakis, Toula, et al.
Publicado: (2018)

Designing an online intervention for adults with addictive eating: a qualitative integrated knowledge translation approach
por: Leary, Mark, et al.
Publicado: (2022)

The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
por: Day-Storms, Jeremy J., et al.
Publicado: (2021)

Mixed-methods study to examine the response of opioid addiction treatment programmes to COVID-19: a study protocol
por: Choi, Sugy, et al.
Publicado: (2022)

Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
por: Kabashi, Saranda, et al.
Publicado: (2021)

Primary care management of Long-Term opioid therapy
por: Coffin, Phillip O., et al.
Publicado: (2022)

Piloting the addition of contingency management to best practice counselling as an adjunct treatment for rural and remote disordered gamblers: study protocol
por: Christensen, Darren R, et al.
Publicado: (2018)

A retrospective chart review of opioid represcribing following nonfatal overdose at a Veterans Affairs hospital
por: Boyle, Julia, et al.
Publicado: (2018)

Record Linkage Approaches Using Prescription Drug Monitoring Program and Mortality Data for Public Health Analyses and Epidemiologic Studies
por: Nechuta, Sarah, et al.
Publicado: (2020)

Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol
por: Auriacombe, Marc, et al.
Publicado: (2019)

Social norms and goal-setting interventions to promote responsible gambling in low-to-moderate online gamblers: protocol for a four-arm randomised controlled feasibility study
por: Arden-Close, Emily, et al.
Publicado: (2023)

Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014)

Two-group randomised, parallel trial of cognitive and exposure therapies for problem gambling: a research protocol
por: Smith, David P, et al.
Publicado: (2013)

Peer support and online cognitive behavioural therapy for substance use concerns: protocol for a randomised controlled trial
por: Quilty, Lena C, et al.
Publicado: (2022)

Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio
por: Young, April M, et al.
Publicado: (2022)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sd8c22jleff36tkjk8151q0nnu